Cellular SAMHD1 levels have previously been shown to critically determine cytarabine efficacy in acute myeloid leukaemia (AML) cells23,24,30 and SAMHD1 expression levels are lower in T-ALL than in AML cells (Supplementary Fig. 5). The gene discussed is SAMHD1; the disease is acute myeloid leukemia.